Search the Newsreel

Nexxen International (NEXN) CFO sells 106,345 shares in Rule 10b5-1 plan trades

Nexxen International's Chief Financial Officer, Niri Sagi, reported the sale of 106,345 shares of common stock through open-market transactions on July 13 and July 15, 2026. The shares were sold at prices of $9.9585 and $10.1585 per share, totaling approximately $1.07 million. These sales …

Nexxen International (NEXN) holder files to sell 35,000 shares

A holder of Nexxen International (NEXN) has filed a Form 144 notice indicating their intent to sell up to 35,000 ordinary shares with an aggregate market value of $358,050. This sale will be facilitated through Oppenheimer & Co. Inc. The shares originated from 75,386 …

Nexxen International (NEXN) Form 144 covers 52,264 ordinary shares

Nexxen International's reporting person Yaniv Carmi submitted a Form 144 detailing the proposed sale of 52,264 ordinary shares through Oppenheimer & Co. Inc. The filing indicates RSU vesting events for 91,463 and 26,133 shares which were issued without cash consideration. It also discloses recent …

Xenon Pharmaceuticals advances with strong Phase 3 epilepsy data, eyeing NDA filing in 2026.

Xenon Pharmaceuticals is progressing with its lead drug candidate, azetukalner, for refractory focal onset seizures, showing strong effectiveness in Phase 3 trials and targeting an NDA filing in Q3 2026. The company is well-funded through 2029 for ongoing trials in other neurological conditions and …

NEXXEN International (NASDAQ: NEXN) lists 73,295 shares for sale

NEXXEN International Ltd. has notified a potential sale of 73,295 ordinary shares, valued at $727,086.40, associated with Oppenheimer & Co. Inc. and Nasdaq as of July 15, 2026. This follows earlier issuances of 82,500 and 577,500 shares upon RSU vesting with no cash consideration. …

Insider Sellers Might Regret Selling Crexendo Shares at a Lower Price Than Current Market Value

Crexendo (NASDAQ:CXDO) stock has risen by 11% in the last week, leading to potential regrets for insiders who sold shares at prices lower than the current market value. Despite recent insider selling, which often signals a lack of confidence, the stock's recent performance suggests …

NEXN SEC Filings - Nexxen International 10-K, 10-Q, 8-K Forms

This page provides access to Nexxen International's (NEXN) SEC filings, including annual reports (20-F), quarterly reports (6-K), and insider trading forms. It highlights Nexxen's status as a NASDAQ-listed foreign private issuer headquartered in Israel, operating a global advertising technology platform. The platform also offers …

Price to sales forward of Xenon Pharmaceuticals Inc. – TRADEGATE:XP0

This page provides financial data for Xenon Pharmaceuticals Inc. (TRADEGATE:XP0), specifically focusing on its forward price-to-sales ratio. The content indicates that the market was closed at the time of viewing, with no current trades.

Xenia Hotels & Resorts (XHR) Gains 1.46% — Testing Key Resistance at $21.07 - Fear Greed Index

XNCR Forecast — Price Target — Prediction for 2027

XBIO Q2 2025 Earnings: EPS Beats Estimates Despite Revenue Absence and Stock Decline - Dividend Growth Analysis

Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call

Citizens reiterates Nexxen stock rating on raised revenue outlook

Xenora Minerals (ASX: XRA) Surges as Junior Resource Stocks Lead ASX Gainers

Nexxen International Ltd. Increases Full-Year 2026 Revenue Guidance Amid Strong Business Momentum

Xenetic Biosciences (XBIO) Q2 2025 Earnings: EPS Surprises to the Upside with Narrower-Than-Expected Loss - Cost Structure Review

How The Nexxen International (NEXN) Narrative Is Shifting As Analysts Rework Targets And Growth Assumptions

Nexxen International DRC earnings beat by $0.02, revenue topped estimates

Nexxen tops quarterly expectations and lifts 2026 revenue outlook (NEXN)

These Analysts Just Made A Huge Downgrade To Their Xencor, Inc. (NASDAQ:XNCR) EPS Forecasts

Nexxen: A Small-Cap Value Proposition With Growth Potential (NASDAQ:NEXN)

Xenia Hotels & Resorts Q1 Earnings Call Highlights

Nexxen International: Cheap For A Reason Until Programmatic Growth Reaccelerates

Is Nexxen International Ltd. Sponsored ADR (NEXN) Stock Outpacing Its Business Services Peers This Year?

Is Nexxen International Ltd. Sponsored ADR (NEXN) Outperforming Other Business Services Stocks This Year?

Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ

Technical Analysis of Xenora Minerals Limited (ASX:XRA)

Should I buy Xenetic Biosciences (XBIO)

Xenetic Biosciences, Inc. Share Price Live Today – NASDAQ:XBIO Stock Price, Chart, News, History

Xencor Reports Massive 82% Revenue Growth as 4 Key Drug Candidates Progress in Clinical Trials

Earnings call transcript: Xenia Hotels & Resorts beats Q1 2025 forecasts

Xenia Hotels & Resorts (XHR) Stock Price, News & Analysis

Nexxen International Ltd. Sponsored ADR (NEXN)

Should I buy Nexxen International Ltd. Sponsored ADR (NEXN)

Xenetic Biosciences Stock Price Forecast. Should You Buy XBIO?

Xenia Hotels & Resorts, Inc. (XHR) stock price, news, quote and history